digital currency map People searches

Bank of America: restore coverage to AbbVie, give it a "neutral" rating, and target price is $191.Kyle Rodda, a financial market analyst in Capital.com, looks forward to the US CPI in November: The expected CPI data basically gives the Fed a green light to cut interest rates next week, which may be the gold catalyst we need to see.It is reported that the performance of Samsung's HBM3E memory can't meet the requirements, so it is difficult to supply it to NVIDIA in 2024. It is reported that Samsung's 8-and 12-layer stacked HBM3E memory samples can't meet the requirements of NVIDIA, so it is difficult to officially start supplying this big customer this year, and the actual supply will fall to 2025. According to the report, Samsung Electronics began to supply quality test samples of HBM3E memory to NVIDIA as early as October 2023, but the certification process of Samsung HBM3E has not made significant progress in more than one year.

Bernstein: Raise the target price of American Airlines from $14 to $24, and upgrade its rating from "keep pace with the market" to "outperform the market".Governor of Belgorod, Russia: Ukrainian troops fired more than 30 shells in Belgorod within 24 hours, causing no casualties or property losses.Changhong Meiling: It plans to use its own idle funds not exceeding 6.35 billion yuan to invest in wealth management products. Changhong Meiling announced that in order to improve the efficiency of the company's use of funds, increase the company's cash assets income, and maximize the interests of shareholders, the company and its subsidiaries (excluding Zhongke Meiling Cryogenic Technology Co., Ltd. and its subsidiaries) will use their own idle funds not exceeding 6.35 billion yuan (this amount can be used in a rolling way) to invest and purchase products with high safety, good liquidity and a term of less than one year.

Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.The People's Procuratorate of Hunan Province decided to arrest Ye Xinping in accordance with the law. The case of Ye Xinping (director level), the former party secretary and chairman of Hunan Construction Engineering Group Co., Ltd., was investigated by Hunan Provincial Supervision Committee and transferred to the procuratorate for examination and prosecution. A few days ago, the Hunan Provincial People's Procuratorate made a decision to arrest Ye Xinping on suspicion of accepting bribes. The case is being further processed.Hualu Hengsheng: The adipic acid plant of nylon 66 high-end new material project was put into production. Hualu Hengsheng (600426) announced on the evening of December 11th that the adipic acid plant of the company's nylon 66 high-end new material project had been put through the process, produced qualified products and entered the trial production stage. Production facilities such as nylon 66 are currently under construction. After the adipic acid plant is put into production, 200,000 tons/year of adipic acid can be added, which lays a foundation for the company to further expand the new chemical materials sector and is conducive to improving the comprehensive competitiveness of enterprises.